Dilanubicel

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of universal, off-the-shelf, ex vivo expanded, allogeneic umbilical cord blood (UCB)-derived hematopoietic stem and progenitor cells (HSPCs) that can potentially be used to improve hematopoietic recovery after chemotherapy or hematopoietic cell transplantation (HCT). Upon administration of dilanubicel, these cells increase and restore the number of HSPCs, which may prevent or decrease infection and other complications of chemotherapy-induced neutropenia (CIN) or cord blood transplantation.

**Synonyms:** - Allogeneic UCB-derived Hematopoietic Stem and Progenitor Cells NLA101 - Allogeneic Umbilical Cord Blood-derived HSPCs NLA101 - DILANUBICEL - NLA101